REFERENCES
- Daiger SP, Bowne, SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol 2007;125(2):151–158
- Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006;368(9549):1795–1809
- Sullivan LS, Bowne SJ, Reeves MJ, et al. Prevalence of mutations in eyeGENE probands with a diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2013;54(9):6255–6261
- Rio Frio T, Wade NM, Ransijn A, et al. Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay. J Clin Invest 2008;118(4):1519–1531
- Vithana EN, Abu-Safieh L, Pelosini L, et al. Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: A molecular clue for incomplete penetrance? Invest Ophthalmol Vis Sci 2003;44(10):4204–4209
- McGee TL, Devoto M, Ott J, et al. Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele. Am J Hum Genet 1997;61(5):1059–1066
- Farkas MH, Lew DS, Sousa ME, et al. Mutations in Pre-mRNA processing factors 3, 8, and 31 cause dysfunction of the retinal pigment epithelium. Am J Pathol 2014;184(10):2641–2652
- Fishman GA, Chappelow AV, Anderson RJ, et al. Short-term inter-visit variability of ERG amplitudes in normal subjects and patients with retinitis pigmentosa. Retina 2005;25(8):1014–1021
- Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008;358(21):2240–2248
- Seiple W, Clemens CJ, Greenstein VC, et al. Test–retest reliability of the multifocal electroretinogram and humphrey visual fields in patients with retinitis pigmentosa. Doc Ophthalmol 2004;109(3):255–272
- Ogura S, Yasukawa T, Kato A, et al. Wide-field fundus autofluorescence imaging to evaluate retinal function in patients with retinitis pigmentosa. Am J Ophthalmol 2014;158(5):1093–1098
- Berson EL, Sandberg MA, Rosner B, et al. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol 1985;99(3):240–251
- Grover S, Fishman GA, Birch DG, et al. Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell disease. Ophthalmology 2003;110(6):1159–1163
- Birch DG, Locke KG, Wen Y, et al. Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol 2013;131(9):1143–1150
- Ramachandran R, Zhou L, Locke KG, et al. A comparison of methods for tracking progression in X-linked retinitis pigmentosa using frequency domain OCT. Transl Vis Sci Technol 2013;2(7):5
- Fischer MD, Fleischhauer JC, Gillies MC, et al. A new method to monitor visual field defects caused by photoreceptor degeneration by quantitative optical coherence tomography. Invest Ophthalmol Vis Sci 2008;49(8):3617–3621
- MacLaren RE, Groppe M, Barnard AR, et al. Retinal gene therapy in patients with choroideremia: Initial findings from a phase 1/2 clinical trial. Lancet 2014;383(9923):1129–1137